Olho seco

Nishiwaki-Dantas, Maria Cristina

doi:10.5935/0004-2749.19990062

Texto completo disponível apenas em PDF.

Agradecimento especial ao Dr. Kazuo Tsubota pela colaboração na revisão deste tema.

REFERÊNCIAS BIBLIOGRÁFICAS

¹ Lemp MA. Dry eye syndromes: treatment and clinical trials. Adv Exp Med Biol 1994;350:553-9.
² Nelson JD. Diagnosis of keratoconjunctivitis sicca. Int Ophthalmol Clin 1994;34(1):37-56.
³ Abelson M & Knight E. Dry eye therapy evaluation of current directions and clinical trials. Adv Exp Med Biol 1994;350:431-6.
⁴ Wolff E. The mucocutaneous junction of the lid and the distribution of the tear fluid. Trans Ophthalmol Soc UK 1946;66:291-308.
⁵ Tiffany JM. Composition and biophysical properties of the tear film knowledge and uncertainty. Adv Exp Med Biol 1994;350:231-8.
⁶ Dilly P N. Structure and function of the tear film. Adv Exp Med Biol 1994;350:239-47.
⁷ Prydal JI & Campbell FW. Study of precorneal tear film thickness and structure by interferometry and confocal microscopy. Invest Ophthalmol Vis Sci 1992;33:1996-2005.
⁸ Prydal JI, Artal P, Woon H & Campbell FW. Study of human precorneal tear film thickness and structure using laser interferometry. Invest Ophthalmol Vis Sci 1992;33:2006-11.
⁹ Chen HB, Yamabayashi S, Ou B, Tanaka Y, Ohni S & Tsukahara S. Structure and composition of rat precorneal tear film. Invest Ophthalmol Vis Sci 1997;38:381-7.
¹⁰ Tabbara KF & Wagoner MD. Diagnosis and management of dry eye syndrome. Int Ophthalmol Clin 1996;61-75.
¹¹ Tsubota K, Fujishima H, Toda I, Katagiri S, Kawashima Y & Saito I. Increased leveis of Epstein Baar virus DNA in lacrimal glands of Sjögren's syndrome patients. Acta Ophthalmol Scandinavia 1995;73:425-30.
¹² Warren DW. Hormonal influences on the lacrimal gland. Int Ophthalmol Clin 1994;34(1):19-26.
¹³ Rocha FJ, Sato EH, Sullivan BD & Sullivan DA. Comparative efficacy of androgen analogues in suppressing lacrimal gland inflammation in a mouse model (MRL/l yr) of Sjögren's syndrome. Adv Exp Med Biol 1994;350:697-700.
¹⁴ Sato EH, Ariga HH & Sullivan DA. Impact of androgen therapy in Sjögren's syndrome: hormonal influence on lymphocyte populations and Ia expression in lacrimal glands of MRL/MP-Ipr mice. Invest Ophthalmol Vis Sci 1992;33(8):2537-45.
¹⁵ Vendramini AC, Soo CH & Sullivan DA. Invest Ophthalmol Vis Sci 1991;32:3002.
¹⁶ Jones LT. The lacrimal secretory system and its treatment. Am J Ophthalmol 1966;62:47-60.
¹⁷ Clinch TE. Benedetto DA, Felbey NT & Laibson PR. Schirmer's test: a closer look. Arch Ophthalmol 1983;101:1383-6.
¹⁸ Lamberts DW, Foster CS & Perry HD. Schirmer test after topical anesthetic and the tear meniscus in normal eyes. Arch Ophthalmol 1979;97:1082-5.
¹⁹ Van Birjsterveld OP. Diagnostic teses in the sicca syndrome. Arch Ophthalmol 1969;82:10-4.
²⁰ Tsubota K. The importance of the Schirmer test with nasal stimulation. Am J Ophthalmol 1991;111(1):106-8.
²¹ Adamson TC, Fox RI, Frisman DM & Howell FV. Immunohystologic analysis of lymphoid infiltrates in primary Sjögren's syndrome using monoclonal antibodies. J Immunol 1983;130:204.
²² Berfort R & Mendes NF. T and B lymphocytes in the human conjunctiva and lacrimal gland. ln: Silverstein A, O'Connor RG, eds. Immunology and Immunopathology of the Eye. New York: Masson Publishing, 1979;287.
²³ Fox RI, Robinson CA, Curd JG, Kozin F & Howell FV. Sjögren's syndrome. Proposed criteria for classification. Arthritis and Rheum 1986;29(5):577-85.
²⁴ Xu KP, Yagi Y & Tsubota K. Decreased in corneal sensivity and change in tear function in dry eye. Cornea 1996;15(3):235-9.
²⁵ Lemp MA & Harnill JR. Factors affecting tear break up in normal eyes. Arch Ophthalmol 1973;89:103-5.
²⁶ Mengher LS, Bron AJ, Tonge SR & Gilbert DJ. A non invasive instrument for clinicai assessment of the pre corneal tear film stability. Curr Eye Res 1985;4:9-!2.
²⁷ Feenstra RPC & Tseng SCG. What is actually stained by rose bengal? Arch Ophthalmol 1992; 110:984-93.
²⁸ Manning FJ, Webely SR & Foulks GN. Patient tolerance and ocular surface staining characteristics of lissamine green versus rose bengal. Ophthalmology 1995; 102(12):1953-7.
²⁹ Tseng SCG. Evaluation of the ocular surface in dry eye conditions. Int Ophthalmol Clin 1994;34(1):57-69.
³⁰ Xu KP & Tsubota K. Correlation of the tear clearance rate and fluorophotometric assessment of tear turnover. Br J Ophthalmol 1995;79: 1042-5.
³¹ Xu KP, Yagi Y, Toda I & Tsubota K. Tear function index. Arch Ophthalmol 1995; 1134:84-8.
³² Tsubota K & Nakamori K. Effects of ocular surface area and blink rate on tear dynarnics. Arch Ophthalmol 1995;113:155-8.
³³ Tsubota K & Yamada M. Tear evaporation from the ocular surface. Invest Ophthalmol Vis Sci 1992;33:2942-50.
³⁴ Gilbard JP, Farris FL & Santamaria J. Osmolarity of tear microvolumes in keratoconjunctivitis sicca. Arch Ophthalmol 1978;96:677-81.
³⁵ Tabbara KF & Okumoto M. Ocular fernicy test: a qualitative test for mucus deficiency. Ophthalmology 1982;89:712-4.
³⁶ Morgan PB, Tullo AB & Efron N. Infrared thermography of the tear film in dry eye. Eye 1995;19:615-8.
³⁷ Fujishima H, Toda I, Yamada M, Sato N & Tsubota K. Corneal temperature in patients with dry eye evaluated by infrared radiation thermometry. Br J Ophthalmol 1996;80:29-32.
³⁸ Yagi Y, Fujushima H, Shimazaki J & Tsubota K. Cooled eye drops reduce corneal sensation and produce comfortableness. Invest Ophthalmol Vis Sci (Suppl) 1994;35:1671.
³⁹ Lemp MA. Management of the dry eye patient. Int Ophthalmol Clin 1994;34(1): 101-13.
⁴⁰ Lemp MA. Recent developments in dry eye management. In: Cavanagh HD, ed. Transactions of the World Congress on the Cornea III. New York: Raven Press Ltd, 1988;9-13.
⁴¹ Tsubota K. New approaches in dry eye therapy. Int Ophthalmol Clin 1994;34(1):115-28.
⁴² Sibley M. Artificial tear issues. Adv Exp Med Biol 1994;350:437-40.
⁴³ Toda I, Shinozaki N & Tsubota K. Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjögren's syndrome. Cornea 1996;15(2): 120-8.
⁴⁴ Murube J & Murube E. Treatment of dry eye by blocking the lacrimal canaliculi. Surv Ophthalmol 1996;40(6):463-80.
⁴⁵ Diamond JP, Morgan JE, Virjee J & Easty DL. Canalicular occlusion with cyanoacrylate adhesive: a new treatment for the dry eye. Eye 1995;9:126-9.
⁴⁶ Tsubota K, Yamada M & Urayama K. Spectacle side paneis and moist inserts for the treatment of dry eye patients. Cornea 1994;13(3):197-201.
⁴⁷ Korb DR, Greiner JV, Glonek J, Esbah R, Finnemore VM & Whalen AC. Effect of periocular hurnidity in tear film lipid layer. Cornea 1996; 15(2): 129-34.
⁴⁸ Faarris RL. Contact lenses and the dry eye. Int Ophthalmol Clin 1994;34(1):129-36.
⁴⁹ Tseng SCG, Maumenee DE, Stark WJ. Topical retinoids treatment for various dry eye disorders. Ophthalmology 1985;92:917-27.

Datas de Publicação

Publicação nesta coleção
Fev 1999

Este é um artigo publicado em acesso aberto (Open Access) sob a licença Creative Commons Attribution, que permite uso, distribuição e reprodução em qualquer meio, sem restrições desde que o trabalho original seja corretamente citado.

[1] ¹ Lemp MA. Dry eye syndromes: treatment and clinical trials. Adv Exp Med Biol 1994;350:553-9.

[2] ² Nelson JD. Diagnosis of keratoconjunctivitis sicca. Int Ophthalmol Clin 1994;34(1):37-56.

[3] ³ Abelson M & Knight E. Dry eye therapy evaluation of current directions and clinical trials. Adv Exp Med Biol 1994;350:431-6.

[4] ⁴ Wolff E. The mucocutaneous junction of the lid and the distribution of the tear fluid. Trans Ophthalmol Soc UK 1946;66:291-308.

[5] ⁵ Tiffany JM. Composition and biophysical properties of the tear film knowledge and uncertainty. Adv Exp Med Biol 1994;350:231-8.

[6] ⁶ Dilly P N. Structure and function of the tear film. Adv Exp Med Biol 1994;350:239-47.

[7] ⁷ Prydal JI & Campbell FW. Study of precorneal tear film thickness and structure by interferometry and confocal microscopy. Invest Ophthalmol Vis Sci 1992;33:1996-2005.

[8] ⁸ Prydal JI, Artal P, Woon H & Campbell FW. Study of human precorneal tear film thickness and structure using laser interferometry. Invest Ophthalmol Vis Sci 1992;33:2006-11.

[9] ⁹ Chen HB, Yamabayashi S, Ou B, Tanaka Y, Ohni S & Tsukahara S. Structure and composition of rat precorneal tear film. Invest Ophthalmol Vis Sci 1997;38:381-7.

[10] ¹⁰ Tabbara KF & Wagoner MD. Diagnosis and management of dry eye syndrome. Int Ophthalmol Clin 1996;61-75.

[11] ¹¹ Tsubota K, Fujishima H, Toda I, Katagiri S, Kawashima Y & Saito I. Increased leveis of Epstein Baar virus DNA in lacrimal glands of Sjögren's syndrome patients. Acta Ophthalmol Scandinavia 1995;73:425-30.

[12] ¹² Warren DW. Hormonal influences on the lacrimal gland. Int Ophthalmol Clin 1994;34(1):19-26.

[13] ¹³ Rocha FJ, Sato EH, Sullivan BD & Sullivan DA. Comparative efficacy of androgen analogues in suppressing lacrimal gland inflammation in a mouse model (MRL/l yr) of Sjögren's syndrome. Adv Exp Med Biol 1994;350:697-700.

[14] ¹⁴ Sato EH, Ariga HH & Sullivan DA. Impact of androgen therapy in Sjögren's syndrome: hormonal influence on lymphocyte populations and Ia expression in lacrimal glands of MRL/MP-Ipr mice. Invest Ophthalmol Vis Sci 1992;33(8):2537-45.

[15] ¹⁵ Vendramini AC, Soo CH & Sullivan DA. Invest Ophthalmol Vis Sci 1991;32:3002.

[16] ¹⁶ Jones LT. The lacrimal secretory system and its treatment. Am J Ophthalmol 1966;62:47-60.

[17] ¹⁷ Clinch TE. Benedetto DA, Felbey NT & Laibson PR. Schirmer's test: a closer look. Arch Ophthalmol 1983;101:1383-6.

[18] ¹⁸ Lamberts DW, Foster CS & Perry HD. Schirmer test after topical anesthetic and the tear meniscus in normal eyes. Arch Ophthalmol 1979;97:1082-5.

[19] ¹⁹ Van Birjsterveld OP. Diagnostic teses in the sicca syndrome. Arch Ophthalmol 1969;82:10-4.

[20] ²⁰ Tsubota K. The importance of the Schirmer test with nasal stimulation. Am J Ophthalmol 1991;111(1):106-8.

[21] ²¹ Adamson TC, Fox RI, Frisman DM & Howell FV. Immunohystologic analysis of lymphoid infiltrates in primary Sjögren's syndrome using monoclonal antibodies. J Immunol 1983;130:204.

[22] ²² Berfort R & Mendes NF. T and B lymphocytes in the human conjunctiva and lacrimal gland. ln: Silverstein A, O'Connor RG, eds. Immunology and Immunopathology of the Eye. New York: Masson Publishing, 1979;287.

[23] ²³ Fox RI, Robinson CA, Curd JG, Kozin F & Howell FV. Sjögren's syndrome. Proposed criteria for classification. Arthritis and Rheum 1986;29(5):577-85.

[24] ²⁴ Xu KP, Yagi Y & Tsubota K. Decreased in corneal sensivity and change in tear function in dry eye. Cornea 1996;15(3):235-9.

[25] ²⁵ Lemp MA & Harnill JR. Factors affecting tear break up in normal eyes. Arch Ophthalmol 1973;89:103-5.

[26] ²⁶ Mengher LS, Bron AJ, Tonge SR & Gilbert DJ. A non invasive instrument for clinicai assessment of the pre corneal tear film stability. Curr Eye Res 1985;4:9-!2.

[27] ²⁷ Feenstra RPC & Tseng SCG. What is actually stained by rose bengal? Arch Ophthalmol 1992; 110:984-93.

[28] ²⁸ Manning FJ, Webely SR & Foulks GN. Patient tolerance and ocular surface staining characteristics of lissamine green versus rose bengal. Ophthalmology 1995; 102(12):1953-7.

[29] ²⁹ Tseng SCG. Evaluation of the ocular surface in dry eye conditions. Int Ophthalmol Clin 1994;34(1):57-69.

[30] ³⁰ Xu KP & Tsubota K. Correlation of the tear clearance rate and fluorophotometric assessment of tear turnover. Br J Ophthalmol 1995;79: 1042-5.

[31] ³¹ Xu KP, Yagi Y, Toda I & Tsubota K. Tear function index. Arch Ophthalmol 1995; 1134:84-8.

[32] ³² Tsubota K & Nakamori K. Effects of ocular surface area and blink rate on tear dynarnics. Arch Ophthalmol 1995;113:155-8.

[33] ³³ Tsubota K & Yamada M. Tear evaporation from the ocular surface. Invest Ophthalmol Vis Sci 1992;33:2942-50.

[34] ³⁴ Gilbard JP, Farris FL & Santamaria J. Osmolarity of tear microvolumes in keratoconjunctivitis sicca. Arch Ophthalmol 1978;96:677-81.

[35] ³⁵ Tabbara KF & Okumoto M. Ocular fernicy test: a qualitative test for mucus deficiency. Ophthalmology 1982;89:712-4.

[36] ³⁶ Morgan PB, Tullo AB & Efron N. Infrared thermography of the tear film in dry eye. Eye 1995;19:615-8.

[37] ³⁷ Fujishima H, Toda I, Yamada M, Sato N & Tsubota K. Corneal temperature in patients with dry eye evaluated by infrared radiation thermometry. Br J Ophthalmol 1996;80:29-32.

[38] ³⁸ Yagi Y, Fujushima H, Shimazaki J & Tsubota K. Cooled eye drops reduce corneal sensation and produce comfortableness. Invest Ophthalmol Vis Sci (Suppl) 1994;35:1671.

[39] ³⁹ Lemp MA. Management of the dry eye patient. Int Ophthalmol Clin 1994;34(1): 101-13.

[40] ⁴⁰ Lemp MA. Recent developments in dry eye management. In: Cavanagh HD, ed. Transactions of the World Congress on the Cornea III. New York: Raven Press Ltd, 1988;9-13.

[41] ⁴¹ Tsubota K. New approaches in dry eye therapy. Int Ophthalmol Clin 1994;34(1):115-28.

[42] ⁴² Sibley M. Artificial tear issues. Adv Exp Med Biol 1994;350:437-40.

[43] ⁴³ Toda I, Shinozaki N & Tsubota K. Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjögren's syndrome. Cornea 1996;15(2): 120-8.

[44] ⁴⁴ Murube J & Murube E. Treatment of dry eye by blocking the lacrimal canaliculi. Surv Ophthalmol 1996;40(6):463-80.

[45] ⁴⁵ Diamond JP, Morgan JE, Virjee J & Easty DL. Canalicular occlusion with cyanoacrylate adhesive: a new treatment for the dry eye. Eye 1995;9:126-9.

[46] ⁴⁶ Tsubota K, Yamada M & Urayama K. Spectacle side paneis and moist inserts for the treatment of dry eye patients. Cornea 1994;13(3):197-201.

[47] ⁴⁷ Korb DR, Greiner JV, Glonek J, Esbah R, Finnemore VM & Whalen AC. Effect of periocular hurnidity in tear film lipid layer. Cornea 1996; 15(2): 129-34.

[48] ⁴⁸ Faarris RL. Contact lenses and the dry eye. Int Ophthalmol Clin 1994;34(1):129-36.

[49] ⁴⁹ Tseng SCG, Maumenee DE, Stark WJ. Topical retinoids treatment for various dry eye disorders. Ophthalmology 1985;92:917-27.

Olho seco

Dry eye

REFERÊNCIAS BIBLIOGRÁFICAS

Datas de Publicação